Enzymotec (ENZY) Tops Q1 EPS by 3c

Enzymotec (NASDAQ: ENZY) reported Q1 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $12.25 million versus the consensus estimate of $12.1 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M